Select Publications
Conference Papers
, 2010, 'Macrophage inhibitory cytokine 1 (MIC-1) serum levels in the Lipodystrophy Case Definition Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A28 - A29, presented at
, 2010, 'Predictors of limb fat changes in patients switched to tenofovir-emtricitabine or abacavir-lamivudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A7 - A7, presented at
, 2010, 'Predictors of limb fat changes in patients switched to tenofovir-emtricitabine or abacavir-lamivudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A7 - A7, presented at
, 2010, 'Glutamate excitotoxicity, cortical and subcortical neuronal damage as potential markers of HIV-associated neurocognitive disorder (HAND): A 1H-MRS and neuropsychological study', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, ITALY, Milan, pp. 22 - 23, presented at
, 2009, 'Evaluation of adipose gene expression and mitochondrial DNA in healthy adults over a 6 week course of NRTI and/or PI treatment. Indications of divergent effects', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A10 - A11, presented at
, 2008, 'Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy', in Circulation, http://dx.doi.org/10.1161/CIRCULATIONAHA.107.189624
, 2008, 'Continuous antiretroviral therapy decreases bone mineral density: results from the SMART study', in Antiviral Therapy, Int Medical Press Ltd, London, England, pp. A26 - A26, presented at
, 2006, 'Metabolic syndrome in HIV-infected patients using IDF and ATPIII criteria: prevalence, discordance and clinical utility', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CA, San Francisco, pp. L4 - L4, presented at
, 2006, 'Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV-infected adults', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CA, San Francisco, pp. L4 - L4, presented at
, 2004, 'HIV drug adverse events: Selected highlights from the 15th International AIDS Conference', in HIV Clinical Trials, pp. 252 - 256, http://dx.doi.org/10.1310/43UQ-4UTE-4RDE-B5UY
, 2003, 'HIV Lipodystrophy Case Definition Study Group. Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. 57 - 57
, 2003, 'Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. L73 - L73
, 2002, 'Disrupted expression of lipid transport genes in monocytes of individuals with HIV-associated lipodystrophy - an additional risk for cardiovascular disease?', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L8 - L9, presented at
, 2002, 'Haematological changes in patients randomized to HAART regimens containing either zidovudine or stavudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L60 - L60, presented at
, 2002, 'The effect of centralized body composition data analysis on an objective case definition of HIV lipodystrophy', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L53 - L53, presented at
, 1994, 'Primary infection with Zidovudine-resistant human immunodeficiency virus type 1 does not adverseley affect outcome at 1 year', in Journal of Infectious Diseases, University of Chicago Press, Chicago, IL, presented at
, 1993, 'Roundtable discussion: Management issues in didanosine therapy', in Journal of Acquired Immune Deficiency Syndromes, pp. S51 - S55
Conference Posters
, 2019, 'Methamphetamine users in the EPIC-NSW study report high adherence to pre-exposure prophylaxis (PrEP)', Perth, Western Australia, presented at Australian HIV and AIDS Conference, Perth, Western Australia, 17 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/965b72bcb63f490083f4c0b91255431c
, 2019, 'STI incidence and risk factors in HIV-infected adults on antiretrovrial therapy (ART) in the PAART study', Perth, Australia, presented at Joint Australasian Sexual Health and HIV&AIDS Conference, Perth, Australia, 16 September 2019 - 19 September 2019
, 2019, 'Safety of oral lisdexamfetamine in adults with methamphetamine dependence: a dose-escalating phase-2 study', San Antonio, Texas, USA, presented at The College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, Texas, USA, 15 June 2019 - 19 July 2019
, 2018, 'Failure of antiretroviral therapy (ART) in adults in Australia is mainly due to ART toxicity (an updated report with predictors of ART failure)', Sydney, Australia, presented at The Australasian HIV&AIDS Conference, Sydney, Australia, 24 September 2018 - 26 September 2018
, 2018, 'Failure of antiretroviral therapy (ART) in adults in Australia is mainly due to ART toxicity (updated report with predictors of ART failure)', Amsterdam, the Netherlands, presented at 22nd International AIDS Conference, Amsterdam, the Netherlands, 23 July 2018 - 27 July 2018
, 2018, 'Hospitalisations over a year follow-up in a cohort of adults living with HIV with sustained viral suppression in Australia', Amsterdam, the Netherlands, presented at 22nd International AIDS Conference, Amsterdam, the Netherlands, 23 July 2018 - 27 July 2018
, 2017, 'Socioeconomic and psychosocial factors are associated with suboptimal outcomes in HIV-infected adults: a case-control analysis', Canberra, Australia, presented at The Australasian HIV&AIDS Conference, Canberra, Australia, 06 November 2017 - 08 November 2017
, 2017, 'Failure of antiretroviral therapy (ART) in Australian adults is mainly due to ART toxicity', Milan, Italy, presented at The 16th European AIDS Conference, Milan, Italy, 25 October 2017 - 27 October 2017
, 2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', Milan, Italy, presented at The 16th European AIDS Conference, Milan, Italy, 25 October 2017 - 27 October 2017
, 2017, 'Socioeconomic and psychosocial factors are associated with suboptimal outcomes in HIV-infected adults: a case-control analysis', Milan, Italy, presented at The 16th European AIDS Conference, Milan, Italy, 25 October 2017 - 27 October 2017
, 2017, 'High adherence to HIV pre-exposure prophylaxis (PrEP) in participants presenting for month 12 visit in PRELUDEopen-label study in NSW, Australia', Paris, France, presented at International AIDS Society, Paris, France, 23 July 2017 - 26 July 2017, http://programme.ias2017.org/Abstract/Abstract/3358
, 2015, 'Characteristics of Gay Men in Sydney using HIV Pre-Exposure Prophylaxis (PrEP): Baseline Data from the PrELUDE Study', Brisbane, Australia, presented at Australian HIV and AIDS Conference, Brisbane, Australia, 16 September 2015
, 2014, 'Safety and tolerability of, and adherence to, co-formulated emtricitabine-rilpivirine-tenofovir used as HIV non-occupational post-exposure prophylaxis in men who have sex with men', Sydney, Australia, presented at The St Vincent’s and Mater Health Research Symposium, Sydney, Australia, 11 September 2014 - 11 September 2014
, 2013, 'Predictors of adherence to antiretroviral therapy in HIV-infected adults (the PAART pilot study)', Darwin, Australia, presented at The Australasian HIV&AIDS Conference, Darwin, Australia, 21 October 2013 - 23 October 2013
Conference Presentations
, 2018, 'Hospitalisations over a year follow-up in a cohort of adults living with HIV with sustained viral suppression in Australia', presented at The Australasian HIV&AIDS Conference, Sydney, Australia, 24 September 2018 - 26 September 2018
, 2017, 'Failure of antiretroviral therapy (ART) in Australian adults is mainly due to ART toxicity', presented at The Australasian HIV&AIDS Conference, Canberra, Australia, 06 November 2017 - 08 November 2017
, 2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', presented at The Australasian HIV&AIDS Conference, Canberra Australia, 06 November 2017 - 08 November 2017
, 2016, 'Concomitant medication use in ART-experienced adults: data from the PAART study', presented at The Australasian HIV&AIDS Conference, Adelaide, Australia, 16 November 2016 - 18 November 2016
, 2015, 'Parameters associated with adherence to antiretroviral therapy in HIV-infected Australian adults: the PAART study', presented at The Australasian HIV&AIDS Conference, Brisbane, Australia, 16 September 2015 - 18 September 2015
Conference Abstracts
, 2019, 'Cardiovascular Disease Risk Factors and HIV Disease Markers Increase Dementia Risk and Alter White Matter Microstructure in Virally Suppressed HIV Infected Men', in JOURNAL OF NEUROVIROLOGY, SPRINGER, GA, Atlanta, Vol. 25, pp. S6 - S7, presented at 16th International Symposium on NeuroVirology, GA, Atlanta, 12 November 2019 - 16 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000495782800020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'The natural history of anal high grade squamous intraepithelial lesions in HIV positive and HIV negative gay and bisexual men', in HIV MEDICINE, WILEY, Vol. 20, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494690300029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'COGNITIVE EFFECTS OF ESCALATING DOSES OF ORAL LISDEXAMFETAMINE IN METHAMPHETAMINE DEPENDENT ADULTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'EFFECT OF SWITCH FROM TENOFOVIR TO RALTEGRAVIR ON TRABECULAR BONE SCORE', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, SINGAPORE, Singapore, Vol. 27, pp. S725 - S725, presented at IOF-Regionals 6th Asia-Pacific Osteoporosis Meeting, SINGAPORE, Singapore, 04 November 2016 - 06 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000388955600072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LISDEXAMFETAMINE FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE: THE LIMA STUDY PROTOCOL', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 35 - 36, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Concomitant medication use in ART-experienced Australian adults: data from the PAART Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, NY, New York, Vol. 21, pp. A50 - A50, presented at 18th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV, NY, New York, 12 September 2016 - 13 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000389747500044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'T-cells in the anal mucosa of men with high- grade squamous intraepithelial lesions', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 240 - 240, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400486&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'COMPARISON OF THE FREELITE (TM) SERUM FREE LIGHT CHAIN (SFLC) ASSAY WITH SERUM AND URINE ELECTROPHORESIS/IMMUNOFIXATION AND THE N LATEX FLC ASSAY', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360834700077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'T-CELLS IN THE ANAL MUCOSA OF MEN WITH HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 91, pp. A168 - A168, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000416106400440&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2012, 'PERCEPTION OF INTOXICATION FOLLOWING ALCOHOL AND ENERGY DRINK CONSUMPTION', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 31, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Theses / Dissertations
, 2018, Antiretroviral therapy and treatment cascade outcomes in a cohort of adults living with HIV in Australia
Preprints
, 2024, Self-reactive B cells traverse a perfect storm of somatic mutagenesis to cause a virus-induced autoimmune disease, http://dx.doi.org/10.1101/2024.01.07.574561
, 2020, Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study, http://dx.doi.org/10.21203/rs.3.rs-30957/v1